PO.CL01.05 · 临床研究
Biomarkers Predictive of Therapeutic Benefit 5
-
-
-
-
-
-
-
-
-
- 5244 5244 基因组HLA I类等位基因失衡削弱晚期非小细胞肺癌的持久免疫治疗应答 Genomic HLA class I allelic imbalance undermines enduring immunotherapy response in advanced non small cell lung cancer Yiting Dong#, Shun Wang#, Wenbin Li*, Zhijie Wang*, Jie Wang*
-
-
-
-
-
-
-
-
-
- 5255 5255 KRAS亚型可能改变胰腺癌对免疫治疗的不良应答：来自早期临床试验的证据 KRAS subtype may modify the poor immunotherapy response in pancreatic cancer: Evidence from early phase trials Dilsa Mizrak Kaya, Yangruijue Ma, Tarik Demir, Aparna Kalyan, Sheetal Kircher, Mary Mulcahy, Al B. Benson III, Ruohui Chen, Devalingam Mahalingam
- 5256 5256 NME1、CXCL12、VDR、DNMT1、CAV1、IL27和IL33多态性与孟加拉国女性乳腺癌易感性的关联：一项病例对照与计算机模拟研究 Association of NME1, CXCL12, VDR, DNMT1, CAV1, IL27, and IL33 polymorphisms with breast cancer susceptibility in Bangladeshi women: A case-control and in silico study Mohammad Safiqul Islam, Md Abdul Barek
-
-
-
-
